17 alpha-hydroxyprogesterone caproate has been researched along with Uterine Neoplasms in 36 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 32 (88.89) | 18.7374 |
| 1990's | 4 (11.11) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| HENRIKSEN, E; VARGA, A | 1 |
| BAGINSKY, S; KISTNER, RW | 1 |
| Bokhman, IaV; Tkeshelashvili, VT; Vishnevskiĭ, AS | 1 |
| Botnar', ER; Chernyĭ, AP; Shendereva, TS; Shvedova, LA; Volostnykh, LV | 1 |
| Rodriguez, L; Schindler, C | 1 |
| Bassalyk, LS; Ermilova, VD; Kuz'mina, ZV; Murav'eva, NI; Peskova, VI | 1 |
| Shvedova, LA | 1 |
| Bokhman, JV; Chepick, OF; Vishnevsky, AS; Volkova, AT | 2 |
| Kozbagarova, RG; Nigaĭ, SV; Nigmatullina, AA; Smakhtina, OL | 1 |
| Lebedeva, AV; Malysheva, SF; Shuvaeva, NI; Vekhova, LI | 1 |
| Onsrud, M | 2 |
| Bokhman, IaV; Chepik, OF; Vishnevskiĭ, AS; Volkova, AT | 2 |
| Pavlovich, T; Schindler, C | 1 |
| Schindler, C | 1 |
| Schindler, C; Schober, J | 1 |
| Shenderëva, TS; Shvedova, LA | 1 |
| Bernshteĭn, MI; Evtiukhin, AI; Kolotova, NG; Smirnova, EV; Volkova, AT | 1 |
| Bochmann, JW | 1 |
| Gosh, TE; Nevskaia, EA; Nikitina, NI; Shuvaeva, NI; Vekhova, LI | 1 |
| Bobrov, JF; Bokhman, JV; Chepick, OF; Shtofmakher, JA; Sofroniy, DF; Tsyrlina, EV; Vishnevsky, AS | 1 |
| Titova, VA; Voznyĭ, EK | 1 |
| Bakhidze, EV | 1 |
| Bobrov, IuF; Bokhman, IaV; Fel'dkoren, BI; Tsyrlina, EV; Vishnevskiĭ, AS | 1 |
| Abeler, V; Kjørstad, K; Kolstad, P; Vergote, I | 1 |
| Bobrov, IuF; Bokhman, IaV; Shtofmakher, IA; Tsyrlina, EV; Vishnevskiĭ, AS | 2 |
| Haug, E; Kjørstad, K; Onsrud, M; Paus, E | 1 |
| Fujimoto, J; Fujita, H; Nakata, Y; Okada, H | 1 |
| Eichhorn, KH; Franke, D; Hempel, E; Nöschel, H; Rasch, A | 1 |
| Akobdzhanian, MA; Lipets, VIa | 1 |
| Bokhman, IaV; Gastev, AIu; Stoliarova, IV | 1 |
| Mori, T; Noda, Y; Ozasa, H | 1 |
| Decker, DG; Edmonson, JH; Jefferies, JA; Malkasian, GD; O'Brien, PC; Podratz, KC | 1 |
4 trial(s) available for 17 alpha-hydroxyprogesterone caproate and Uterine Neoplasms
| Article | Year |
|---|---|
Adjuvant hydroxyprogesterone caproate in stage I endometrial carcinoma: changes in numbers and reactivities of some blood lymphocyte subpopulations.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Female; Humans; Hydroxyprogesterones; Killer Cells, Natural; Leukocytes; Middle Aged; Neoplasm Staging; Progesterone Congeners; T-Lymphocytes; Uterine Neoplasms | 1982 |
A randomized trial of adjuvant progestagen in early endometrial cancer.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adenocarcinoma; Clinical Trials as Topic; Combined Modality Therapy; Estrogen Antagonists; Female; Humans; Hydroxyprogesterones; Neoplasm Recurrence, Local; Progesterone Congeners; Prognosis; Random Allocation; Risk Factors; Uterine Neoplasms | 1989 |
[Effect of adjuvant hormonotherapy on the results of the radiation treatment of patients with cancer of the corpus uteri].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adenocarcinoma; Clinical Trials as Topic; Combined Modality Therapy; Female; Humans; Hydroxyprogesterones; Neoplasm Staging; Prognosis; Radiotherapy Dosage; Random Allocation; Uterine Neoplasms | 1987 |
Serum lipids and lipoproteins in patients with endometrial carcinoma receiving adjuvant treatment with hydroxyprogesterone caproate.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Cholesterol; Cholesterol, HDL; Clinical Trials as Topic; Combined Modality Therapy; Female; Humans; Hydroxyprogesterones; Lipids; Lipoproteins; Lipoproteins, HDL; Middle Aged; Time Factors; Triglycerides; Uterine Neoplasms | 1985 |
32 other study(ies) available for 17 alpha-hydroxyprogesterone caproate and Uterine Neoplasms
| Article | Year |
|---|---|
Clinical and histopathologic evaluation of the effect of 17-alpha-hydroxyprogesterone-17-n-caproate on endometral carcinoma.
Topics: 17 alpha-Hydroxyprogesterone Caproate; 17-alpha-Hydroxyprogesterone; Adenocarcinoma; Adenocarcinoma, Papillary; Caproates; Female; Humans; Hydroxyprogesterones; Progesterone; Uterine Neoplasms | 1961 |
Observations on the use of 17-alpha-hydroxy-progesterone caproate on primary metastatic endometrial carcinoma.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Endometrial Neoplasms; Female; Humans; Hydroxyprogesterones; Progesterone; Uterine Neoplasms | 1961 |
[Planning of the treatment of atypical hyperplasia of the endometrium in patients with uterine myoma].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Age Factors; Chlormadinone Acetate; Combined Modality Therapy; Contraceptives, Oral, Combined; Dilatation and Curettage; Drug Combinations; Drug Therapy, Combination; Endometrial Hyperplasia; Ethynodiol Diacetate; Female; Humans; Hydroxyprogesterones; Leiomyoma; Mestranol; Middle Aged; Norethindrone; Time Factors; Uterine Neoplasms | 1984 |
[Combined morphologic evaluation of the efficacy of progestin therapy of primary endometrial cancer].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adenocarcinoma; Biopsy; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Humans; Hydroxyprogesterones; Neoplasm Recurrence, Local; Time Factors; Uterine Neoplasms | 1984 |
[Comparative studies of the effect on the in vitro growth of endometrial cancers of hydroxyprogesterone caproate, norethisterone acetate and D-norgestrel].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Cells, Cultured; Drug Evaluation, Preclinical; Drug Resistance; Female; Humans; Hydroxyprogesterones; Norethindrone; Norethindrone Acetate; Norgestrel; Uterine Neoplasms | 1984 |
[Cytoplasmic steroid hormone receptors in the tumors of endometrial cancer patients].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adenocarcinoma; Combined Modality Therapy; Cytoplasm; Female; Humans; Hydroxyprogesterones; Menopause; Middle Aged; Preoperative Care; Receptors, Estrogen; Receptors, Progesterone; Uterine Neoplasms | 1984 |
[Effect of treatment with synthetic progestins on indices of the liver protein-forming function in uterine cancer patients].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Blood Proteins; Female; Humans; Hydroxyprogesterones; Liver; Progesterone Congeners; Protein Biosynthesis; Uterine Neoplasms | 1984 |
Adjuvant hormone therapy of primary endometrial carcinoma with oxyprogesterone caproate.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adenocarcinoma; Female; Humans; Hydroxyprogesterones; Hysterectomy; Postoperative Care; Preoperative Care; Progesterone Congeners; Radiotherapy, High-Energy; Uterine Neoplasms | 1981 |
[Hormonal therapy of cancer of the corpus uteri].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Aged; Female; Humans; Hydroxyprogesterones; Middle Aged; Preoperative Care; Progesterone Congeners; Uterine Neoplasms | 1983 |
[The role of hormone therapy in the treatment of cancer of the endometrium].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Age Factors; Aged; Female; Humans; Hydroxyprogesterones; Middle Aged; Postoperative Care; Progesterone Congeners; Uterine Neoplasms | 1983 |
[Is a cure possible for primary state-I endometrial cancer using drug therapy?].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adenocarcinoma; Adult; Antineoplastic Agents; Carcinoma; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Hydroxyprogesterones; Neoplasm Staging; Preoperative Care; Uterine Neoplasms | 1982 |
[Comparison of the results of gestagen therapy of cancer of the corpus uteri with a preliminary study of tumor cell culture sensitivity to the preparations].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Cells, Cultured; Drug Evaluation; Drug Evaluation, Preclinical; Drug Resistance; Female; Humans; Hydroxyprogesterones; Norethindrone; Norgestrel; Progesterone Congeners; Uterine Neoplasms | 1982 |
[Use of gestagens to control in vitro growth of endometrial carcinoma (author's transl)].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Cells, Cultured; Drug Resistance; Female; Humans; Hydroxyprogesterones; Norethindrone; Norgestrel; Progestins; Uterine Neoplasms | 1981 |
[Results obtained from gestagen treatment of patients for endometrial carcinoma, with particular reference to results obtained from in vitro tests before treatment (author's transl)].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Drug Resistance; Female; Humans; Hydroxyprogesterones; Neoplasm Staging; Norethindrone; Norethindrone Acetate; Norgestrel; Uterine Neoplasms | 1981 |
[Hormonal transformation characteristics of endometrial adenoacanthoma in the process of progestin treatment].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adenocarcinoma; Adult; Biopsy; Cell Transformation, Neoplastic; Drug Evaluation; Female; Humans; Hydroxyprogesterones; Middle Aged; Progesterone Congeners; Uterine Neoplasms | 1981 |
[Effect of surgical and combined treatments on the state of the blood coagulating system in cancer of the corpus uteri].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Blood Coagulation; Blood Coagulation Tests; Female; Humans; Hydroxyprogesterones; Hysterectomy; Middle Aged; Postoperative Period; Preoperative Care; Progesterone Congeners; Time Factors; Uterine Neoplasms | 1981 |
[Adjuvant gestagen therapy of endometrial carcinoma (author's transl)].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adenocarcinoma; Adult; Female; Humans; Hydroxyprogesterones; Hysterectomy; Middle Aged; Neoplasm Staging; Progesterone Congeners; Prognosis; Uterine Neoplasms | 1981 |
[Clinico-morphological changes during treatment of endometrial cancer with progestins].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Aged; Caproates; Female; Humans; Hydroxyprogesterones; Middle Aged; Preoperative Care; Uterine Neoplasms | 1980 |
Effect of oxyprogesterone caproate, tamoxifen and their combination on the level of steroid hormone receptors in the tumor, and some parameters of the reproductive system in patients with endometrial cancer.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Antineoplastic Combined Chemotherapy Protocols; Cytoplasm; Estradiol; Female; Follicle Stimulating Hormone; Humans; Hydroxyprogesterones; Luteinizing Hormone; Middle Aged; Receptors, Estradiol; Receptors, Progesterone; Tamoxifen; Uterine Neoplasms; Vagina | 1990 |
[Progestins in combined treatment of endometrial cancer].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Combined Modality Therapy; Drug Therapy, Combination; Estrogen Antagonists; Female; Humans; Hydroxyprogesterones; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Progestins; Uterine Neoplasms | 1990 |
Application of thymic factor "Thymalin" in complex treatment of endometrial cancer patients.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adjuvants, Immunologic; Antineoplastic Agents; Cells, Cultured; Combined Modality Therapy; Estradiol; Female; Humans; Hydroxyprogesterones; Immunity, Cellular; Middle Aged; Rosette Formation; Survival Rate; T-Lymphocyte Subsets; Tamoxifen; Thymus Hormones; Uterine Neoplasms | 1990 |
[Regularities and paradoxes of endocrine dependence and hormonal therapy of endometrial cancer].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adenocarcinoma; Adult; Delayed-Action Preparations; Estrogen Antagonists; Female; Humans; Hydroxyprogesterones; Middle Aged; Pregnancy; Pregnancy Complications, Neoplastic; Progesterone Congeners; Tamoxifen; Uterine Neoplasms | 1990 |
[Effect of progestin therapy on the level of cytoplasmic receptors in patients with cancer of the corpus uteri].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Antineoplastic Agents; Cytoplasm; Drug Evaluation; Female; Homeostasis; Humans; Hydroxyprogesterones; Lymphatic Metastasis; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Preoperative Care; Receptors, Cell Surface; Reproduction; Uterine Neoplasms; Vaginal Smears | 1989 |
[The effect of hydroxyprogesterone caproate and its combination with tamoxifen on steroid hormone receptors in the tumor and on the basic parameters of reproductive homeostasis in patients with cancer of the corpus uteri].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Combined Modality Therapy; Drug Evaluation; Drug Therapy, Combination; Female; Homeostasis; Humans; Hydroxyprogesterones; Middle Aged; Preoperative Care; Progesterone Congeners; Receptors, Estradiol; Receptors, Progesterone; Reproduction; Tamoxifen; Uterine Neoplasms | 1989 |
Intramuscular administration of hydroxyprogesterone caproate in patients with endometrial carcinoma. Pharmacokinetics and effects on adrenal function.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adrenal Glands; Androstenedione; Dehydroepiandrosterone; Estrogen Antagonists; Estrone; Female; Humans; Hydrocortisone; Hydroxyprogesterones; Injections, Intramuscular; Kinetics; Uterine Neoplasms | 1985 |
[Hormone dependency and progestogen therapy in the treatment of endometrial cancer].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Cell Division; Female; Humans; Hydroxyprogesterones; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Norethindrone; Tamoxifen; Tumor Stem Cell Assay; Uterine Neoplasms | 1987 |
[Comparison of the progesterone test and uterus sonography as screening procedures in the detection of patients at risk of endometrial cancer].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Dilatation and Curettage; Female; Humans; Hydroxyprogesterones; Mass Screening; Middle Aged; Risk Factors; Ultrasonography; Uterine Neoplasms; Uterus | 1988 |
[Structural characteristics of the pathologically changed uterus after treatment with sex hormones].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Endometriosis; Endometrium; Female; Humans; Hydroxyprogesterones; Leiomyoma; Middle Aged; Testosterone; Uterine Neoplasms | 1985 |
[Effects of tamoxifen and oxyprogesterone caproate on steroid hormone receptors in tumors and indicators of reproductive homeostasis in patients with cancer of the uterine body].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Endometrium; Female; Gonadotropins, Pituitary; Humans; Hydroxyprogesterones; Middle Aged; Prolactin; Receptors, Estradiol; Receptors, Progesterone; Tamoxifen; Uterine Neoplasms | 1988 |
Progesterone increases serum CA-125 in endometriosis.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Antigens, Neoplasm; Antigens, Tumor-Associated, Carbohydrate; Endometriosis; Enzyme-Linked Immunosorbent Assay; Estradiol; Female; Follicular Phase; Humans; Hydroxyprogesterones; Injections, Intramuscular; Middle Aged; Progesterone; Radioimmunoassay; Time Factors; Uterine Neoplasms | 1987 |
Can primary endometrial carcinoma stage I be cured without surgery and radiation therapy?
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Humans; Hydroxyprogesterones; Methotrexate; Progesterone Congeners; Uterine Neoplasms; Vincristine | 1985 |
Effects of progestational agents in treatment of endometrial carcinoma.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Female; Humans; Hydroxyprogesterones; Medrogestone; Megestrol; Neoplasm Recurrence, Local; Progesterone Congeners; Prognosis; Time Factors; Uterine Neoplasms | 1985 |